Boehringer Ingelheim Romania's 2010 Turnover Up 27.6% To RON100.6M

04.28.2011 By Andrei Circhelan

German drug maker Boehringer Ingelheim on Thursday said its turnover in Romania was at 100.6 million lei (EUR24.7 million) last year, up 27.6% from RON78.8 million in 2009, mainly fueled by exports.

German drug maker Boehringer Ingelheim on Thursday said its turnover in Romania was at 100.6 million lei (EUR24.7 million) last year, up 27.6% from RON78.8 million in 2009, mainly fueled by exports.

Prescription drugs generated some 85% of the company's revenue in 2010, namely RON87.2 million, while the over-the-counter drugs brought sales of RON13.4 million.

Exports to Germany and UK contributed to the increase in sales last year, Boehringer Ingelheim Romania general manager Franz Zinsberger told a news conference.

For this year, the company plans to grow higher than the market average.

The Romanian pharmaceutical market is expected to increase by 7.4% this year, to RON10.95 billion, according to research company IMS Health Romania.

Boehringer Ingelheim has some 100 employees in Romania and it ranks 23rd among the local players in terms of Romanian sales.

The company has been active on the Romanian market since 1976.

The Boehringer group operates through 145 affiliated companies worldwide, with some 42,000 employees.